Nadler Financial Group, Inc. Bristol Myers Squibb CO Transaction History

Nadler Financial Group, Inc.

$850 Million
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $17,077 - $19,095	-295 Reduced 7.61%	3,581 $207,000
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $19,431 - $21,575	305 Added 8.54%	3,876 $247,000
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $46,259 - $52,469	704 Added 24.56%	3,571 $247,000
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $1,643 - $1,946	24 Added 0.84%	2,867 $206,000
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $369 - $218,456	2,843 New	2,843 $202,000
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $303,096 - $363,439	-4,930 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $20,272 - $23,632	-378 Reduced 7.12%	4,930 $307,000
Q3 2021 Oct 13, 2021	SELL	$59.17 - $69.31 $3,313 - $3,881	-56 Reduced 1.04%	5,308 $314,000
Q2 2021 Jul 16, 2021	BUY	$61.91 - $67.42 $2,600 - $2,831	42 Added 0.79%	5,364 $358,000
Q1 2021 Apr 14, 2021	SELL	$59.34 - $66.74 $72,928 - $82,023	-1,229 Reduced 18.76%	5,322 $336,000
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $10,970 - $12,431	190 Added 2.99%	6,551 $406,000
Q3 2020 Oct 07, 2020	BUY	$57.43 - $63.64 $75,290 - $83,432	1,311 Added 25.96%	6,361 $384,000
Q2 2020 Jul 09, 2020	BUY	$54.82 - $64.09 $3,234 - $3,781	59 Added 1.18%	5,050 $297,000
Q1 2020 Apr 09, 2020	SELL	$46.4 - $67.43 $89,134 - $129,533	-1,921 Reduced 27.79%	4,991 $278,000
Q4 2019 Jan 08, 2020	BUY	$49.21 - $64.19 $109,098 - $142,309	2,217 Added 47.22%	6,912 $444,000
Q3 2019 Oct 03, 2019	SELL	$42.77 - $50.71 $28,570 - $33,874	-668 Reduced 12.46%	4,695 $238,000
Q2 2019 Jul 16, 2019	SELL	$44.62 - $49.34 $11,110 - $12,285	-249 Reduced 4.44%	5,363 $243,000
Q1 2019 Apr 04, 2019	SELL	$45.12 - $53.8 $721 - $860	-16 Reduced 0.28%	5,612 $268,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $8,825 - $11,444	-181 Reduced 3.12%	5,628 $293,000
Q3 2018 Oct 09, 2018	BUY	$55.19 - $62.25 $827 - $933	15 Added 0.26%	5,809 $361,000
Q2 2018 Jul 10, 2018	BUY	$50.53 - $62.98 $3,587 - $4,471	71 Added 1.24%	5,794 $321,000
Q1 2018 Apr 05, 2018	SELL	$59.92 - $68.98 $30,619 - $35,248	-511 Reduced 8.2%	5,723 $362,000
Q4 2017 Jan 12, 2018	BUY	$59.94 - $65.35 $719 - $784	12 Added 0.19%	6,234 $382,000
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $343,641 - $396,590	6,222	6,222 $397,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nadler Financial Group, Inc. with notifications on news.

Account